MedTrace Logo

A Safety Follow Up Study in Australian Subjects Implanted With the SMF Short Modular Femoral Stem Hip System

NCT03646513 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2024-03-19

Study results available
· View outcomes & findings →

Summary

This is a prospective, single arm, sequential enrolment study to collect relevant clinical and radiological data in approximately 26 subjects, at one site in Australia, who have been implanted with the SMF Short Modular Femoral Stem Hip System in a primary THA procedure to assess its safety and efficacy up to 20 years post-surgery.

Conditions

  • Total Hip Arthroplasty (THA)

Interventions

DEVICE

SMF Short Modular Femoral Hip System

Primary Total Hip Arthroplasty with SMF Short Modular Femoral Stem Hip System.

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Stephen McMahon · Malabar Orthopaedic Institute, Melbourne, Australia.

Eligibility

Min Age
55 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-14
Primary Completion
2020-03-12
Completion
2020-03-12

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03646513 on ClinicalTrials.gov